jRCT2071210040已完成不适用
Safety, tolerability, and pharmacokinetics of single rising oral doses of BI 474121 in healthy Japanese male subjects (doubleblind, randomised, placebo-controlled, parallel group design)
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 32
- 主要终点
- -
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized Controlled Trial
- 干预模型
- Parallel Assignment
- 主要目的
- Treatment Purpose
- 盲法
- Double Blind
入排标准
- 年龄范围
- 20age old over 至 45age old under（—）
- 性别
- Male
入选标准
- •Healthy male subjects according to the assessment of the investigator, as based on a
- •complete medical history including a physical examination, vital signs (blood
- •pressure[BP], PR) including body temperature, 12-lead ECG, and clinical laboratory tests
- •at screening visit
排除标准
- •Any finding in the medical examination (including BP, PR or ECG) deviating from normal and assessed as clinically relevant by the investigator at screening visit
结局指标
主要结局
-
Percentage of subjects with drug-related adverse events
次要结局
未报告次要终点
研究者
相似试验
已完成
1 期
A study in healthy men to test how BI 1569912 is processed in the body2023-510464-12-00Boehringer Ingelheim International GmbH8
已完成
1 期
A study in healthy men to test how BI 764198 is processed in the body2022-502327-22-00Boehringer Ingelheim International GmbH16
已完成
1 期
A study in healthy people to test how BI 1015550 is taken up in the body when given with or without food2023-509889-38-00Boehringer Ingelheim International GmbH18
招募中
不适用
A study to test whether BI 764524 helps people with an eye condition called diabetic retinopathy (CRIMSON)jRCT2071240025Boehringer Ingelheim Pharma GmbH & Co. KG18
已完成
1 期
A phase I study to determine the tolerability and safety of transdermally delivered oxycodone in combination with the novel penetration enhancer tocopheryl phosphate mix (TPM).To promote pain relief in healthy volunteers.Anaesthesiology - Pain managementACTRN12609000836235Phosphagenics Limited44